Versono Medical Ltd

About

Versono Medical Ltd is an early-stage MedTech company based in Galway, Ireland, founded in 2017 or 2018. The company focuses on developing innovative technologies for endovascular surgery, specifically targeting Critical Limb Ischemia (CLI), a severe form of Peripheral Arterial Disease (PAD). Versono aims to improve patient outcomes by enabling minimally invasive treatments for complex chronic total occlusions (CTOs) and acute vascular occlusions. The core offering of Versono is the FastWire Technology Platform, an intravascular ultrasonic system designed to serve as a reliable guidewire alternative. This technology helps to cross occlusions, prepare a working lumen, and support follow-on devices, ultimately reducing amputation risks and enhancing endovascular outcomes. Versono has raised approximately $7 million in funding and operates from advanced facilities in Galway's MedTech hub, leveraging a skilled team with extensive expertise in vascular devices.